Discover six obesity deals made so far in 2025, with dealmaking activity in the field being largely dominated by big pharma companies.
Discover the emergence of dual-payload ADCs and PDCs, which could mark a significant evolution in targeted therapeutics.
Lonza helps biotech firms accelerate from DNA to IND with tailored strategies that reduce risk and speed complex biologics to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback